PACMILIMAB

UNII:	ZXP96ZI2RA
Formula:
Preferred Substance Name:	PACMILIMAB
GSRS Full Record:	ZXP96ZI2RA i

2145091-51-4
CX072
CX-072
CX-072 PROBODY
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH-LIGAND 1) (HUMAN MONOCLONAL CX-072 .GAMMA.4-CHAIN), DISULFIDE WITH PRODOMAIN PROTEIN (SYNTHETIC MASKING MOIETY AND CLEAVABLE MOIETY PROTEASE SUBSTRATE-CONTAINING) FUSION PROTEIN WITH HUMAN MONOCLONAL CX-072 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PROGRAMMED CELL DEATH 1 LIGAND 1 (PDCD1 LIGAND 1, B7 HOMOLOG 1, CD274 ANTIGEN))HOMO SAPIENS MONOCLONAL ANTIBODY.GAMMA.4 HEAVY CHAIN (1-442) (VH (HOMO SAPIENS IGHV3-23*03 (93%) (IGHD)-IGHJ4*01) (8.8.9) (1-116)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(224)), CH3(K107>DEL(443))) (117-442)), (130-264')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-264') (N-TERMINAL REGION ''MASK'' (1'-21')-TRIGLYCYLDISERYLDIGLYCYLBIS(SERYLDIGLYCYL) LINKER (22'-34') PROTEASE CLEAVABLE REGION (35'-47') DIGLYCYLSERYL LINKER (48'-50') V-KAPPA (HOMO SAPIENS IGKV1-39*01 (96%) IGKJ4*01)(6.3.9) (51'-157')-HOMO SAPIENS IGKC*01(158'-264')), DIMER (222-222'':225-225'')-BISDISULFIDE
PACMILIMAB [INN]
PACMILIMAB [USAN]
PACMILIMAB [WHO-DD]
PROTEASE-ACTIVATED ANTI-PD-L1 ANTIBODY PRODRUG CX-072

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

PACMILIMAB

Synonyms and Mappings

Resources